IGI, Laboratories, Inc. (IG) was a big mover last session, as the company shares rose over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent trend for the company, as the stock is now up over 41% in the past one-month time frame.
In the last 30 days, the company has seen two positive estimate revisions and its Zacks Consensus Estimate also moved higher, suggesting strength down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
IGI, Laboratories currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other well-performing stocks in the med-drugs industry include Endo International plc (ENDP), Hyperion Therapeutics, Inc. (HPTX) and Lannett Company, Inc. (LCI). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment